Literature DB >> 30203740

Noninvasive Sweat-Based Diagnosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis.

Roshan Kamal Topno1, Vikas Shankar2, Manas Ranjan Dikhit3, Major Madhukar4, Krishna Pandey4, V N R Das4, Maneesh Kumar5, Bipin Kumar4, Kanhaiya Agrawal4, Niyamat Ali Siddiqui6, Ganesh Chandra Sahoo3, Rishikesh Kumar5, Ashish Kumar Singh7, Rajeev Kumar8, Dharmendra Singh9, Pradeep Das10.   

Abstract

The diagnosis of visceral leishmaniasis (VL) is one of the foremost barriers in the control of this disease, as demonstration of the parasite by splenic/bone marrow aspiration is relatively difficult and requires expertise and laboratory support. The aim of the present study was to find a noninvasive diagnostic approach using the existing recombinant kinesine-39 (rK-39) immunochromatographic nitrocellulose strips test (ICT) with a human sweat specimen for the diagnosis of VL. The investigation was carried out on specimens (blood, sweat, and urine) collected from 58 confirmed VL, 50 confirmed post kala-azar dermal leishmaniasis (PKDL), 36 healthy control, and 35 patients from other diseases. The data obtained from this study reveal that 96.6% clinically confirmed active VL participants were found to be positive when tested against a sweat specimen. Interestingly, the scenario was similar when tested against a blood specimen (96.6% positive by rK-39). Moreover, a test of both sweats and blood specimens from 50 PKDL participants resulted in 100% positivity, whereas no healthy control participants were found to be rK-39 positive. The sensitivity of the rK-39 ICT in sweat specimen was 94.7%, whereas the specificity was 100% in healthy controls from endemic, nonendemic, and other infectious diseases, respectively. No difference was observed in sweat specimen of VL and PKDL cases which signifies its reliability. However, further evaluation of this method on a larger scale could enhance the reliability of the proposed model so that it could be used efficiently in VL management and eradication.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30203740      PMCID: PMC6221248          DOI: 10.4269/ajtmh.17-0749

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Testing urine samples with rK39 strip as the simplest non-invasive field diagnosis for visceral leishmaniasis: an early report from eastern India.

Authors:  R P Goswami; R P Goswami; S Das; Y Ray; M Rahman
Journal:  J Postgrad Med       Date:  2012 Jul-Sep       Impact factor: 1.476

2.  Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India.

Authors:  Kamlesh Gidwani; Rajiv Kumar; Madhukar Rai; Shyam Sundar
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

3.  Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs.

Authors:  M Mamun Huda; Siddhivinayak Hirve; Niyamat Ali Siddiqui; Paritosh Malaviya; Megha Raj Banjara; Pradeep Das; Sangeeta Kansal; Chitra Kumar Gurung; Eva Naznin; Suman Rijal; Byron Arana; Axel Kroeger; Dinesh Mondal
Journal:  BMC Public Health       Date:  2012-11-20       Impact factor: 3.295

4.  Development of Vaccines against Visceral Leishmaniasis.

Authors:  Krystal J Evans; Lukasz Kedzierski
Journal:  J Trop Med       Date:  2011-09-05

5.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 6.  Potential non-invasive urine-based antigen (protein) detection assay to diagnose active visceral leishmaniasis.

Authors:  Claudia Abeijon; Antonio Campos-Neto
Journal:  PLoS Negl Trop Dis       Date:  2013-05-30

7.  Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.

Authors:  Epco Hasker; Paritosh Malaviya; Kamlesh Gidwani; Albert Picado; Bart Ostyn; Sangeeta Kansal; Rudra Pratap Singh; Om Prakash Singh; Ankita Chourasia; Abhishek Kumar Singh; Ravi Shankar; Mary E Wilson; Basudha Khanal; Suman Rijal; Marleen Boelaert; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2014-01-23

8.  A Comparative Study of Serum, Urine and Saliva Using rk39 Strip for the Diagnosis of Visceral Leishmaniasis.

Authors:  Sarita Mohapatra; Jyotish C Samantaray; Arnab Ghosh
Journal:  J Arthropod Borne Dis       Date:  2015-06-27       Impact factor: 1.198

Review 9.  Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  J Parasitol Res       Date:  2015-12-30

10.  Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.

Authors:  Ajay Amit; Manas R Dikhit; Raj K Pandey; Kuljit Singh; Ritesh Mishra; V N R Das; Pradeep Das; Sanjiva Bimal
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

View more
  3 in total

Review 1.  Biomarkers in Post-kala-azar Dermal Leishmaniasis.

Authors:  Eduard E Zijlstra
Journal:  Front Cell Infect Microbiol       Date:  2019-07-31       Impact factor: 5.293

Review 2.  Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani.

Authors:  Malcolm S Duthie; Yasuyuki Goto; Prakash Ghosh; Dinesh Mondal
Journal:  Pathog Dis       Date:  2019-08-01       Impact factor: 3.166

3.  Molecular Tracking of the Leishmania Parasite.

Authors:  Srija Moulik; Shilpa Sengupta; Mitali Chatterjee
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.